ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Sunshine Biopharma, Inc. 

6100 Royalmount Avenue

Montreal  Quebec  H4P 2R2  Canada
Phone: 514-496-5197 Fax: 450-689-639


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Sunshine Biopharma, Inc. Increases The Effectiveness Of Adva-27a Lead Compound 9.5-Fold Against Breast And Pancreatic Cancer In Vitro 4/8/2014 10:31:00 AM    More...
Management Of Sunshine Biopharma, Inc. Alarmed By The Recent World Health Organization Report That Cancer Is On The Rise 4/1/2014 9:36:35 AM    More...
Sunshine Biopharma, Inc. Begins Construction Of Mouse Xenograft Models For Pancreatic Cancer To Advance Adva-27a As A Treatment For This Deadly Form Of Cancer 2/17/2014 10:33:47 AM    More...
Sunshine Biopharma, Inc. Continues Its Efforts To Re-Domicile In Canada For Business Expansion And Financing Opportunities For Adva-27a Cancer Drug Candidate 2/5/2014 9:44:28 AM    More...
Sunshine Biopharma, Inc. Targets Pancreatic Cancer As Second Indication For Clinical Trials Of Adva-27a Compound 1/21/2014 10:08:08 AM    More...
Sunshine Biopharma, Inc. Parent Company Acquires Garmen Laboratories, a Certified GMP Manufacturing Lab 8/26/2013 8:39:18 AM    More...
Sunshine Biopharma, Inc. Parent Company Receives $510,000 Research Grant for Adva-27a Cancer Drug Candidate, Brings Total to $1.45 Million 8/12/2013 10:31:55 AM    More...
Sunshine Biopharma, Inc.: Court Ruling on Human Genes Patentability Didn't Affect Tasks 6/19/2013 7:15:25 AM    More...
Sunshine Biopharma, Inc. Announces That Its Breast Cancer Drug Candidate, Adva-27a, Also Destroys Pancreatic Cancer Cells 6/4/2013 10:12:46 AM    More...
Sunshine Biopharma, Inc. Narrows Kilogram Manufacturing Options for Adva-27a Breast Cancer Drug Candidate to Three Suppliers 5/1/2013 11:55:21 AM    More...
12345